Can big data unlock better GERD treatment for chinese patients?

NCT ID NCT07749989

Recruiting now Knowledge-focused Sponsor: Beijing Friendship Hospital Source: ClinicalTrials.gov ↗

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study looks back at the medical records of about 5,000 Chinese patients with gastroesophageal reflux disease (GERD) to build a detailed picture of their symptoms, treatments, and quality of life. The goal is to understand how GERD affects people in China and how well different treatments work. By analyzing this information, researchers hope to find patterns that can help doctors personalize care for each patient.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: This research could lead to better ways to classify and treat GERD, especially for Chinese patients, by identifying which treatments work best for different patient profiles.
What could go wrong: Because this is an observational study using existing medical records, it cannot prove cause and effect. The findings may not apply to patients outside this specific hospital or country.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL REFLUX DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastroesophageal reflux disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROESOPHAGEAL REFLUX DISEASE

Contacts and locations

Locations

Beijing Friendship Hospital, Capital Medical University
RECRUITING

Beijing, Beijing Municipality, 100050, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.